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OBJECTIVES We evaluated the effect of African American (AA) and Hispanic American (HA) ethnicity
on mortality and complications following coronary artery bypass graft (CABG) surgery in the
Veterans Health Administration (VHA).
BACKGROUND Few studies have examined the impact of ethnicity on outcomes following cardiovascular
procedures.
METHODS This study included all 29,333 Caucasian, 2,570 AA, and 1,525 HA patients who underwent
CABG surgery at any one of the 43 VHA cardiac surgery centers from January 1995 through
March 2001. We evaluated the relationship between ethnicity (AA vs. Caucasian and HA vs.
Caucasian) and 30-day mortality, 6-month mortality, and 30-day complications, adjusting for
a wide array of demographic, cardiac, and noncardiac variables.
RESULTS After adjustment for baseline characteristics, AA and Caucasian patients had similar 30-day
(AA/Caucasian odds ratio [OR] 1.07; 95% confidence interval [CI] 0.84 to 1.35; p  0.59)
and 6-month mortality risk (AA/Caucasian OR 1.10; 95% CI 0.91 to 1.34; p  0.31).
However, among patients with low surgical risk, AA ethnicity was associated with higher
mortality (OR 1.52, CI 1.10 to 2.11, p  0.01), and AA patients were more likely to
experience complications following surgery (OR 1.28; 95% CI 1.14 to 1.45; p  0.01). In
contrast, HA patients had lower 30-day (HA/Caucasian OR 0.70; 95% CI 0.49 to 0.98; p 
0.04) and 6-month mortality risk (HA/Caucasian OR 0.66; 95% CI 0.50 to 0.88; p  0.01)
than Caucasian patients.
CONCLUSIONS Ethnicity does not appear to be a strong risk factor for adverse outcomes following CABG
surgery in the VHA. Future studies are needed to determine why AA patients have more
complications, but ethnicity should not affect the decision to offer the operation. (J Am Coll
Cardiol 2002;40:1786–93) © 2002 by the American College of Cardiology Foundation
The influence of race on cardiovascular procedure use and
outcomes has been an area of extensive investigation. Many
studies have found that non-Caucasian race in general, and
African American (AA) and Hispanic American (HA)
ethnicity in particular, are associated with lower rates of
cardiovascular procedure use, including cardiac catheteriza-
tion, percutaneous coronary intervention (PCI), and coro-
nary artery bypass graft (CABG) surgery (1–12). Factors
such as differences in baseline clinical characteristics, disease
severity, reluctance by AA patients to undergo invasive
cardiac procedures, and overuse of procedures in Caucasians
may explain some of the observed differences in cardiac
procedure use (13–17).
The impact of ethnicity on outcomes following coronary
revascularization is less clear. One potential concern is that
if racial minorities are less likely to be referred for cardiac
catheterization and coronary revascularization, then only
those with particularly advanced disease or compelling
indications may undergo these procedures, leading to worse
outcomes. Several studies have reported worse survival for
AA patients following CABG surgery (18–21), whereas
other studies have reported similar survival between Cauca-
sian and AA patients following the operation (22–25). To
our knowledge, no previous studies have evaluated compli-
cation rates or examined post-CABG outcomes in HA
patients.
The goal of this study was to compare 30-day mortality,
30-day complication rates, and 6-month mortality following
CABG surgery for AA and HA patients in comparison to
Caucasian patients in the Veterans Health Administration
(VHA). This included an evaluation of the relationship
between estimated preoperative risk of the patients and
outcomes in order to determine whether differences in
baseline risk were leading to differences in outcome. Our
hypothesis was that outcomes would be equivalent across
racial groups after controlling for differences in baseline
clinical characteristics.
METHODS
Study population. The study population was derived from
the VHA Continuous Improvement in Cardiac Surgery
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Program (CICSP) database. The CICSP has prospectively
collected clinical data on all patients undergoing cardiac
surgery in the VHA since 1987 (26,27). Trained clinical
nurse reviewers located at each of the 43 Veterans Affairs
(VA) cardiac surgical centers collect preoperative risk, sur-
gical procedural, and outcome data (30-day complications
and mortality) on all cardiac surgery patients. Patients were
included in this study if they underwent CABG-only
surgery (i.e., no valve surgery) at any of the VA cardiac
surgical centers from January 1995 through March 2001,
and were of Caucasian, AA, or HA race/ethnicity. Of
37,786 patients who underwent CABG-only surgery in the
VHA during this period, race/ethnicity was missing in
1,616 patients (4.3%), and 2,742 patients (7.3%) were of
other races/ethnicities, giving a final study population of
33,428 patients. The final study population was comprised
of 29,333 Caucasian (87.7%), 2,570 AA (7.7%), and 1,525
HA patients (4.6%). The terms “race” and “ethnicity” are
variably used in the literature to describe AA, HA, and
Caucasian patients. For consistency, we use the term “eth-
nicity” throughout the rest of this paper.
Variables. The three outcome variables for this study were:
1) 30-day all-cause mortality, 2) 6-month all-cause mortal-
ity, and 3) 30-day complication rates. Mortality assessments
were done using: 1) the VHA Beneficiary Identification and
Record Locator System, shown to be comparable with the
National Death Index for mortality assessment in a VA
population (28); and 2) individual follow-up by CICSP
personnel utilizing the VHA national computerized patient
record system and individual patient/family telephone calls.
Complications were assessed by chart review and individual
follow-up by the CICSP nurse reviewers at each site.
Complications included renal failure requiring dialysis, me-
diastinitis, respiratory complications (on a ventilator for
48 h), cardiac complications (repeat cardiopulmonary
bypass or cardiac arrest requiring cardiopulmonary resusci-
tation), re-operation for bleeding, and neurologic compli-
cations (coma or stroke). Outcome assessment (both com-
plications and mortality) is felt to be close to 100% complete
in the VA CICSP database.
The primary predictor variable for this study was ethnic-
ity (AA, HA, and Caucasian). A wide array of preoperative
variables, including demographic, cardiac, and noncardiac
factors, as well as intraoperative variables such as number
and types of grafts used, were available for risk adjustment
(Table 1). These variables included established risk variables
for 30-day and 6-month mortality, and 30-day complica-
tions (26,27,29–31).
Statistical analyses. The objective of this study was to
determine whether AA and/or HA patients are at differen-
tial risk for adverse outcomes compared with Caucasian
patients following CABG surgery. Therefore, Caucasian
ethnicity was the referent group for all analyses, and two
comparisons were made: 1) AA versus Caucasian and 2)
HA versus Caucasian. Baseline characteristics of the study
population were compared between AA and Caucasian
patients, and between HA and Caucasian patients, using t
tests for continuous variables and chi-square tests for cate-
gorical variables.
30-DAY AND 6-MONTH MORTALITY. The unadjusted associ-
ation between AA (vs. Caucasian) and HA (vs. Caucasian)
ethnicity and both 30-day and 6-month mortality were
evaluated using chi-square tests, and Kaplan-Meier curves
were developed to compare unadjusted 6-month survival
between ethnicity groups. Multiple linear regression models
were then developed to assess the impact of AA and HA
ethnicity on 30-day and 6-month mortality after adjusting
for all of the variables listed in Table 1. Interactions between
ethnicity and several risk factors shown to have different
prevalence between ethnicities, including age, diabetes, and
renal insufficiency, were added to the logistic regression
models to determine their significance. Because ethnicity
groups were not evenly distributed across sites, we adjusted
for the proportion of AA and HA patients by site, which
did not alter the results. Regression models were also
developed using backward selection with the variables listed
in Table 1 (p  0.10 for entry; p  0.05 to remain in
model), and then adding the ethnicity variables to these
selected models to assess their significance. The unselected
and selected regression models yielded similar results, and
the parameter estimates from the unselected models are
reported in this paper.
For the six-month mortality outcome, secondary regres-
sion models were developed using Cox proportional hazards
regression to model survival time. The results of the Cox
regression analyses were similar to the logistic regression
analyses and are not reported in this paper. We chose to
report the logistic regression results for comparability to the
30-day mortality models. Furthermore, given the relatively
low risk of death and lack of censoring in this study
population (complete follow-up on all patients), Cox regres-
sion is not more efficient than logistic regression (32), and
logistic regression allows reporting of odds ratios (ORs) that
are easily interpretable.
Secondary analyses were undertaken to further evaluate
the relationship between preoperative risk and ethnicity
because previous studies have suggested that the impact of
ethnicity on 30-day mortality following CABG surgery may
Abbreviations and Acronyms
AA  African American
CABG  coronary artery bypass graft
CI  confidence interval
CICSP  Continuous Improvement in Cardiac Surgery
Program
HA  Hispanic American
LVH  left ventricular hypertrophy
OR  odds ratio
PCI  percutaneous coronary intervention
VA  Veterans Affairs
VHA  Veterans Health Administration
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be most prominent among lower risk patients (18,19). First,
patients were classified into decile groupings based on their
preoperative risk scores (obtained from the 30-day mortality
logistic regression model with ethnicity excluded), and
graphs of risk ratios for 30-day mortality for AA versus
Caucasian and HA versus Caucasian ethnicity across pre-
operative risk deciles were made. Second, we tested the
significance of ethnicity-by-risk interaction in the 30-day
mortality logistic regression model. Finally, the overall
estimated risk of 30-day mortality based on preoperative
characteristics was compared across ethnicity groups, and
comparisons of 30-day and 6-month mortality were made
excluding the highest risk patients (those in the highest
three deciles estimated preoperative risk). Higher versus
lower risk was not defined a priori, but sensitivity analyses
were undertaken altering the definition of high risk (i.e., the
highest decile, 2 deciles, 3 deciles, 4 deciles, and 5 deciles)
which did not significantly alter the results.
COMPLICATIONS. For the primary analyses, complications
were dichotomized as one or more versus no complications
within 30 days following surgery. Chi-square tests were
used to assess the bivariate association between the ethnicity
variables and complications. Multiple logistic regression
models were then developed to assess the impact of AA and
HA ethnicity on 30-day complications, adjusting for the
variables listed in Table 1. Secondary analyses were per-
formed evaluating each of the individual complications
separately.
All statistical analyses were done using SAS version 8.02
(SAS Institute, Cary, North Carolina). Power calculations
were done using PASS software 2000 (NCSS, Kaysville,
Utah). We had 80% power to detect a 1% difference in





(n  2,570) p Value*
Hispanic American
(n  1,525) p Value†
Demographic
Age (mean, SD), yrs 63.6 (9.4) 62.2 (10.0)  0.01 63.8 (9.25) 0.51
Gender (% male) 98.9 98.9 0.91 99.5 0.03
Body surface area (mean, SD) 2.01 (0.192) 2.00 (0.194) 0.10 1.90 (0.179)  0.01
Cardiac
Prior MI (%) 58.4 56.4 0.05 58.8 0.79
Prior PCI (%) 1.7 2.8  0.01 2.6 0.01
Prior heart surgery (%) 7.6 4.2  0.01 5.4  0.01
Preoperative IABP (%) 5.4 4.9 0.36 6.0 0.31
CCS angina class 3 or 4 (%) 77.5 80.5  0.01 72.8  0.01
NYHA class III or IV (%) 3.5 3.9 0.21 3.5 0.86
Ejection fraction 0.02 0.09
0.55 48.9 45.4 45.8
0.45–0.54 23.1 23.9 23.3
0.35–0.44 16.5 18 18.6
0.34 11.5 12.7 12.4
Three-vessel CAD (%) 71.8 73.3 0.11 75.9  0.01
ST-segment depression on preoperative ECG (%) 19.1 23.7  0.01 22.3  0.01
Preoperative diuretics (%) 23.9 27.4  0.01 22.0 0.10
Preoperative intravenous nitroglycerin (%) 14.9 12.9  0.01 15.9 0.30
Priority of surgery (%)  0.01  0.01
Elective 82.4 86.5 85.0
Urgent 11.5 9.6 9.0
Emergent 6.1 3.9 6.0
IMA graft used (%) 82.4 82.8 0.67 84.4 0.04
Number of anastamoses (mean  SD) 3.18  0.97 3.10  1.01  0.01 3.28  0.94  0.01
Noncardiac
Serum creatinine (mean, SD), mg/dl 1.22 (0.679) 1.43 (1.16)  0.01 1.28 (1.03) 0.03
PVD (%) 23.5 27.9  0.01 27.7  0.01
CVD (%) 21.5 19.8 0.05 17.9  0.01
Diabetes mellitus (%) 31.4 38.1  0.01 47.8  0.01
Current smoker (%) 31.6 34.9  0.01 21.2  0.01
COPD (%) 25.9 19.6  0.01 19.3  0.01
Hypertension (%) 82.6 90.0 0.01 86.8 0.30
Estimated preoperative mortality risk 0.35 0.26
Low (1.6%) 33.3 32.9 33.3
Medium (1.6%–3.2%) 33.0 34.4 34.8
High (3.2%) 33.7 32.7 31.9
*Comparison between African-American and Caucasian cohorts; †comparison between Hispanic American and Caucasian cohorts.
CAD  coronary artery disease; CCS  Canadian Cardiovascular Society; COPD  chronic obstructive pulmonary disease; CVD  cerebrovascular disease; ECG 
electrocardiogram; IABP  intra-aortic balloon pump; IMA  internal mammary artery; MI  myocardial infarction; NYHA  New York Heart Association; PCI 
percutaneous coronary intervention; PVD  peripheral vascular disease.
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30-day mortality between AA and Caucasian patients, and
80% power to detect a 1.5% difference in 30-day mortality
between HA and Caucasian patients. We had 85% power to
detect a 1.5% difference in six-month mortality between AA
and Caucasian patients, and 87% power to detect a 2%
difference in six-month mortality between HA and Cauca-
sian patients.
RESULTS
Baseline characteristics. Baseline characteristics of the
study population are compared between AA, HA, and
Caucasian patients in Table 1. Given the large study
population, many baseline comparisons were statistically
different at the p  0.05 level (33). Therefore, baseline
characteristics with relative differences of 10% or more
between the cohorts are reported in the following text.
Compared with Caucasian patients, AA patients were
more likely to have prior PCI, ST-segment depression on
preoperative electrocardiogram, elevated serum creatinine,
peripheral vascular disease, diabetes, to be current smokers,
and to receive preoperative diuretics. Compared with Cau-
casian patients, HA patients were more likely to have prior
PCI, ST-segment depression on preoperative electrocardio-
gram, peripheral vascular disease, and were 1.5 times more
likely to have diabetes. Conversely, Caucasian patients were
more likely than either AA or HA patients to have prior
heart surgery, chronic obstructive pulmonary disease, and to
be classified as having urgent or emergent surgery. Overall,
there was no significant difference in the estimated preop-
erative mortality risk between AA and Caucasian patients
(p 0.35) or between HA and Caucasian patients (p 0.26).
Unadjusted outcomes. There was no significant difference
in unadjusted 30-day mortality (3.9% vs. 3.6%; p  0.48),
6-month mortality (6.3% vs. 5.8%; p  0.27), or 6-month
survival (log-rank test p value  0.44) between AA and
Caucasian patients (Table 2, Fig. 1). However, AA patients
were more likely to have one or more complications within
30 days following surgery (15.3% vs. 12.2%; p  0.01).
Specifically, AA patients were more likely to have renal
failure requiring dialysis (1.7% vs. 1.0%; p  0.01), respi-
ratory complications (8.4% vs. 6.7%; p  0.01), and re-
operation for bleeding (3.5% vs. 2.6%; p  0.01).
There was a trend toward lower 30-day mortality for HA
patients versus Caucasian patients (2.8% vs. 3.6%; p 
0.09), and HA patients had significantly lower 6-month
mortality (4.5% vs. 5.8%; p  0.04) (Table 2). Hispanic
American patients had significantly better six-month unad-
justed survival than Caucasian patients (log-rank test p value
 0.04) (Fig. 1). The better survival for HA patients was
evident immediately following surgery and persisted
through the follow-up period. There was no significant
difference in 30-day complications (12.1% vs. 12.2%; p 
0.92) between HA and Caucasian patients.
Risk-adjusted outcomes. In the regression models (Table
3), there were no significant differences in overall risk-
adjusted 30-day (OR 1.07; 95% confidence interval [CI]
0.84 to 1.35; p  0.59) or 6-month mortality (OR 1.10;
95% CI 0.91 to 1.34; p 0.31) between AA and Caucasian
patients. There was no significant interaction between AA
ethnicity and age, diabetes, or serum creatinine in the
regression models. However, AA patients were more likely
to have one or more complications within 30 days after the
operation (OR 1.28; 95% CI 1.14 to 1.45; p  0.01), after
adjustment for baseline characteristics.
Figure 2 demonstrates that among lower preoperative risk
patients, AA ethnicity appears to be associated with higher
mortality, and there was a significant interaction between
ethnicity and risk deciles (p  0.02). Excluding the highest
risk patients, AA ethnicity was significantly associated with
both higher 30-day (OR 1.52, CI 1.10 to 2.11, p  0.01)
and 6-month mortality (OR 1.45; CI 1.09 to 1.89; p 
0.01). Furthermore, among lower preoperative risk patients,






30-day mortality 3.6 3.9 0.48 2.8 0.09
6-month mortality 5.8 6.3 0.27 4.5 0.04
30-day complications (one or more
complications)




2.3 2.9 0.06 2.8 0.24
Renal failure requiring dialysis 1.0 1.7  0.01 0.9 0.66
Mediastinitis 1.6 1.4 0.38 1.3 0.34
Respiratory complications (on
ventilator  48 h)
6.7 8.4  0.01 7.1 0.57
Cardiac complications (repeat
cardiopulmonary bypass or
cardiac arrest requiring CPR)
2.8 3.1 0.35 2.3 0.22
Reoperation for bleeding 2.6 3.5  0.01 2.9 0.43
*Values are expressed as percentages except p values; †comparison between African American and Caucasian cohorts;
‡comparison between Hispanic-American and Caucasian cohorts.
CPR  cardiopulmonary resuscitation.
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AA patients had a one-third greater likelihood of having
one or more complications than Caucasian patients (12.3%
vs. 9%; p  0.01). When we adjusted for the incidence of
complications in the mortality prediction model, we found
that AA ethnicity was no longer a significant predictor of
mortality (OR 1.18, CI 0.83 to 1.67; p  0.36). These
findings suggest that increased complications among lower
preoperative risk AA patients led to their higher mortality
compared with low-risk Caucasian patients.
Following risk adjustment, HA patients had significantly
lower 30-day (OR 0.70; 95% CI 0.49 to 0.98; p 0.04) and
6-month mortality (OR 0.66; 95% CI 0.50 to 0.88; p 
0.01) than Caucasian patients (Table 3). There was no
significant interaction between HA ethnicity and age, dia-
betes, or serum creatinine in the regression models. Adjust-
ing for the proportion of HA patients at each site did not
alter the results, suggesting that HA patients were not
merely clustered at sites with good outcomes. Figure 3
suggests that the lower mortality found for HA versus
Caucasian patients may be most prominent for patients with
lower preoperative risk, but there was no significant inter-
action between ethnicity and risk deciles for this cohort (p
0.48). Finally, there was no significant difference in risk-
adjusted 30-day complication rates between HA and Cau-
casian patients (OR 0.96; 95% CI 0.81 to 1.14; p  0.67).
DISCUSSION
The objective of this study was to determine whether AA
and/or HA patients were at increased risk for adverse
outcomes compared with Caucasian patients following
CABG surgery in the VHA. There were some significant
differences in the baseline characteristics of the patients, but
there was no overall difference in preoperative mortality risk
between the ethnicity cohorts. AA and Caucasian patients
had similar overall 30-day and 6-month mortality rates
following CABG surgery. However, among patients who
appeared to be at low risk before CABG surgery, AA
ethnicity was associated with increased mortality. Further-
more, AA patients were more likely to have complications
following the operation, including renal failure requiring
dialysis, respiratory complications, and re-operation for
bleeding. In contrast, HA patients had significantly lower
30-day and 6-month mortality than Caucasian patients, and
there was no significant difference in complications rates
between HA and Caucasian patients.
Figure 1. Six-month Kaplan-Meier survival curves for Caucasian (Cauc.), African American (AA), and Hispanic American (HA) cohorts.
Table 3. Multivariate Risk Models for 30-Day Mortality,
6-Month Mortality, and 30-Day Complications*
Variables OR (CI) p Value
30-day mortality
Caucasian† 1.0 —
African American 1.07 (0.84–1.35) 0.59
Hispanic American 0.70 (0.49–0.98) 0.04
6-month mortality
Caucasian† 1.0 —
African American 1.10 (0.91–1.34) 0.31
Hispanic American 0.66 (0.50–0.88)  0.01
30-day complications‡
Caucasian† 1.0 —
African American 1.28 (1.14–1.45)  0.01
Hispanic American 0.96 (0.81–1.14) 0.67
*Adjusted for the demographic, cardiac, and noncardiac variables listed in Table 1;
†Caucasian  referent group; ‡complications  one or more of the complications
listed in Table 2.
CI  confidence interval; OR  odd ratio.
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Previous studies evaluating the impact of AA ethnicity on
mortality following CABG surgery have had mixed conclu-
sions. Several studies have reported higher mortality for AA
patients following the operation (18–21). Importantly, two
of these studies found higher mortality for AA patients only
among patients with lower preoperative risk (18,19). Other
studies, including two conducted in veteran populations
using administrative datasets, have suggested similar risk-
adjusted survival for AA patients following CABG surgery
(22–25). These studies did not specifically evaluate the
relationship between preoperative risk groups and outcome.
The results of our study may help explain the previous
discrepant published studies. We found that overall mortal-
ity did not differ between AA and Caucasian patients
following CABG surgery, consistent with the previous
studies in veterans. However, we also found that AA
patients who appeared to be at low risk before CABG
surgery had elevated mortality risk compared with low-risk
Caucasian patients, consistent with the results of two
previous studies conducted in non-VHA populations.
The finding of elevated mortality among AA patients
who appeared to be at low risk before CABG surgery in
both this study and prior studies indicates that current
methods of preoperative risk assessment may be inadequate
for AA patients. The greater prevalence of hypertension and
higher baseline serum creatinine in AA patients suggests
that we may underestimate the importance of factors such as
left ventricular hypertrophy (LVH) and mild renal insuffi-
ciency as risk factors for adverse outcome. African American
patients are more likely to have LVH than Caucasians, even
with similar degrees of hypertension, and LVH has been
associated with poor prognosis in other clinical settings
(34,35). Mild renal insufficiency has been associated with
adverse outcomes following CABG surgery (36).
To our knowledge, this is the first study to examine the
impact of ethnicity on complications following CABG
surgery. Overall, AA patients were 25% more likely than
Caucasian patients to have complications following the
operation in this study, and higher complication rates
appeared to explain the elevated mortality seen in lower
Figure 2. Risk ratios for 30-day mortality for African-American versus Caucasian patients across deciles of preoperative risk.
Figure 3. Risk ratios for 30-day mortality for Hispanic American versus Caucasian patients across deciles of preoperative risk.
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preoperative risk AA patients. In other words, many AA
patients who appeared to be at low risk for mortality by
traditional mortality risk factor assessment were actually at
elevated risk for complications, which translated into their
higher mortality risk. The higher risk for renal failure in AA
patients following the operation was not surprising given
the significantly higher baseline serum creatinine of this
population, but the reasons for higher respiratory compli-
cations and re-operation for bleeding are unknown. Future
studies are needed to elucidate the specific reasons for
higher complication rates in AA patients and to devise
strategies to reduce complications following the operation
for these patients. In the interim, clinicians should be aware
of the elevated risk of complications for AA patients, even
among those who appear to be at low mortality risk before
the operation.
The impact of HA ethnicity on outcomes following
CABG surgery has not previously been evaluated. One
previous study found similar 30-day and 1-year mortality
rates between HA and Caucasian patients following myo-
cardial infarction, and one study has reported similar risk-
adjusted mortality following PCI for HA and Caucasian
patients (37,38). Certainly, HA patients do not appear to be
at increased risk for adverse outcomes following CABG
surgery in the VHA. The reasons for lower mortality for
HA patients found in this study are not readily apparent and
warrant further evaluation. The overall risk profiles of the
HA and Caucasian patients were similar, suggesting that
the reason for lower mortality in HAs was not because lower
risk patients were referred for the operation. Also, compli-
cation rates were similar between the two groups, suggesting
that lower complication rate among HAs was not the reason
for their lower mortality rates.
Strengths of this study include the use of an extensive,
prospectively collected clinical dataset for risk adjustment. It
has been shown that clinical data are more accurate than
administrative data for evaluating risk-adjusted outcomes
(39). Furthermore, we were able to evaluate the complete
population of patients who underwent CABG in the VHA
for the six-year period analyzed, thereby avoiding selection
bias in the formation of the study population. We had
complete follow-up data on all patients in the study, and
were able to evaluate complications as well as short- and
intermediate-term mortality. Finally, we had the ability to
evaluate HA patients who have been poorly represented in
published studies.
Potential limitations of this study should be addressed.
First, the results may not be generalizable to non-VA
populations. Second, data were derived retrospectively from
an existing database not specifically designed to address the
question of the impact of ethnicity on outcomes following
CABG surgery, and ethnicity was missing in 4.3% of
patients. However, we know of no a priori reason to expect
that this small percentage of missing ethnicity data would
bias our results. Third, there may be residual confounding in
the relationship between ethnicity and the outcomes evalu-
ated because of unmeasured variables, such as additional
comorbidities, medications, and socioeconomic variables
not captured in the VA cardiac surgery database. It should
be noted that veterans are generally sicker and of lower
socioeconomic status than non-VA populations (40). Also,
there may be postsurgical variables that differ among eth-
nicities that could impact outcomes, but the focus of this
study was to evaluate whether ethnicity is a risk factor for
adverse outcomes from the perspective of preoperative risk
assessment. Finally, this study did not evaluate for possible
bias in referral for coronary angiography, but was instead
focused on outcomes following CABG surgery.
Overall, this study is consistent with previous VHA
studies that have found equal outcomes for minority pa-
tients for a variety of conditions (41–43). It has been
suggested that this may be because the VHA operates a
nationwide, government-funded health care system that has
few financial barriers and, therefore, may promote equal
quality of care for minority patients (42,43). In this case, it
appears that ethnicity is not a strong risk factor for adverse
outcomes following CABG surgery in the VHA. Even
where the relative risks differed statistically (as between
low-risk AA and Caucasian patients), the absolute risk
differences were small, and the overall mortality rates for all
the racial groups were low. Further investigation is needed
to determine why AA patients have a higher risk of
complications and whether this risk can be modified, but in
the meantime ethnicity should not affect the decision to
offer CABG surgery in the VHA.
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